ImmunoVaccine Technologies' IPO

ImmunoVaccine Technologies raised a round of funding on October 01, 2009. Investors include Public.

ImmunoVaccine Technologies Inc. (IVT) is a private biotechnology company developing infectious disease and therapeutic cancer vaccines for human health. IVT has a VacciMax and DepoVax vaccine delivery…

Articles about ImmunoVaccine Technologies' IPO: